RBC Capital Downgrades BioCryst Pharma (BCRX) to Sector Perform
Tweet Send to a Friend
RBC Capital analyst Brian Abraham downgraded BioCryst Pharma (NASDAQ: BCRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
